Pfizer moves beyond COVID vaccines to become leader in cancer, obesity treatments
Two years ago, Pfizer was the envy of the pharmaceutical world, with more than $100 billion in annual sales from its COVID-19 vaccine and antiviral Paxlovid. The post Pfizer moves…
